News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 181–216
- Matches
- 1159
- Sources here
- 17
- Companies here
- 17
Active search
1159 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Insider Selling: Darling Ingredients (NYSE:DAR) EVP Sells $100,312.55 in Stock
Darling Ingredients (NYSE:DAR) Executive Vice President Nicholas James Kemphaus recently sold 1,591 shares of the company's stock for a total of $100,312.55, reducing his ownership by 4.34%. This transaction follows a strong quarterly performance where Darling Ingredients beat earnings estimates, with revenue increasing 16.4% …
Victoria Creamer Sells 4,179 Shares of Charles River Laboratories International (NYSE:CRL) Stock
Victoria Creamer, EVP of Charles River Laboratories International (NYSE:CRL), sold 4,179 shares for over $1.08 million, reducing her holdings by 12.21%. Despite the insider sale, the company recently reported strong quarterly earnings, beating estimates with $3.02 EPS and $1 billion in revenue, and analysts …
Michael Gunnar Knell Sells 6,645 Shares of Charles River Laboratories International (NYSE:CRL) Stock
Michael Gunnar Knell, Chief Accounting Officer at Charles River Laboratories International (NYSE:CRL), recently sold 6,645 shares of the company's stock for approximately $1.73 million, reducing his stake by 35.92%. Despite this insider selling, the company reported strong quarterly earnings, beating analyst estimates, and has …
Charles River (CRL) finance chief sells 6,645 shares after exercising 2,345 options
Michael Gunnar Knell, SVP of Finance and Chief Accounting Officer at Charles River Laboratories International, Inc. (CRL), reported exercising 2,345 stock options and selling 6,645 shares of common stock on August 6, 2026. The options were exercised at strike prices between $179.66 and $208.44, …
James Foster (CRL) files Form 144 for 28,733-share option sale
James Foster, an insider at Charles River Laboratories International, Inc. (CRL), has filed a Form 144 indicating his plan to sell 28,733 shares of common stock. These shares will be acquired through the exercise of stock options for cash on August 10, 2026, with …
Charles River (CRL) EVP Victoria Creamer exercises options and sells 4,179 shares
Victoria L. Creamer, EVP & Chief People Officer of Charles River Laboratories International, Inc. (CRL), exercised stock options for 4,179 shares at $179.66 per share and immediately sold them for $259.16 per share on August 6, 2026. This transaction resulted in approximately $332K pre-tax …
Darling Ingredients (DAR) insider plans Rule 144 sale of 1,591 shares
Darling Ingredients Inc. has filed a Rule 144 notice for an insider to sell 1,591 shares of common stock through Charles Schwab & Co., Inc. The aggregate market value of these shares is $100,312.55, and they are listed on the NYSE. The filing also …
Schwab Trading Activity Index up modestly in July (SCHW:NYSE)
The Charles Schwab Corporation's trading activity index (STAX) showed a modest increase in July, rising to 59.80 from 59.12 in June. Schwab clients were net buyers of ETFs and equities at a two-to-one ratio, indicating continued bullish sentiment among self-directed traders.
Carlisle Companies Incorporated (CSL) Stock Price, News, Quote & History
This page provides comprehensive financial information for Carlisle Companies Incorporated (CSL), including its current stock price, recent news, historical data, and analyst insights. It details the company's operations in building envelope products through its Carlisle Construction Materials and Carlisle Weatherproofing Technologies segments. The stock …
Carlyle Group Inc. Q2 2026: Revenue $1123.5M, EPS $0.37— 10-Q Summary
Carlyle Group Inc. reported its Q2 2026 financial results, with revenue reaching $1123.5M and diluted earnings per share at $0.37, significantly lower than the previous year. Despite a decrease in net income and revenue, the company saw modest growth in management fees and an …
Linqto Continues to Pursue Litigation Against Forge and Schwab to Recover Millions of Dollars in Damages to More than 13,000 Linqto Customers
Company Also Moving Forward With Risk Mitigation Strategies to Exit Bankruptcy as Quickly as Possible SAN JOSE, Calif. & HOUSTON, August 10, 2026--(BUSINESS WIRE)--Linqto, Inc. today announced that it continues to pursue its litigation against Forge Global, Inc. and its owner, The Charles Schwab …
Sharemaestro market context Trend signal started 52 weeks +3.6% · Next-week setup negative 43.7%Arlo Technologies (NYSE:ARLO) Shares Down 7.9% - Here's Why
Arlo Technologies (NYSE:ARLO) saw its shares drop 7.9% during mid-day trading despite exceeding quarterly earnings and revenue expectations. The company reported $0.28 EPS against an expected $0.20 and $155.94 million in revenue against $148.94 million, with revenue up 20.5% year-over-year. Analyst sentiment remains largely …
Schwab Clients Buy Late-July Dips Across Stocks, ETFs and Options
The Schwab Trading Activity Index™ (STAX) increased to 59.80 in July, up slightly from June's 59.12, indicating that Schwab clients were net buyers during late-month market dips. Gen X clients and self-directed traders showed the strongest buying interest, focusing on individual stocks, ETFs, and …
Schwab Trading Activity Index™: STAX Score Increases Modestly in July
Schwab Trading Activity Index vs. S&P 500 (Graphic: Charles Schwab) Schwab clients were net buyers, using late-month dips to add exposure across individual stocks, ETFs, and options Key Takeaways: The Schwab Trading Activity Index™ (STAX) increased to 59.80 in July, up slightly from its …
Sharemaestro market context Trend signal started 52 weeks +3.6% · Next-week setup negative 43.7%Carlyle Group heavily invested in medical supplies giant Medline (MDLN.US) and aviation maintenance giant StandardAero (SARO.US) in Q2, and established a position in AI cloud service provider Nebius (NBIS.US).
Carlyle Group's Q2 2026 13F filing shows a total holdings market value of $10 billion, a slight decrease from the previous quarter. The group heavily invested in medical supplies giant Medline (MDLN.US) and aviation maintenance giant StandardAero (SARO.US), which remain its top two holdings, …
Charles River Laboratories , Inc. Stock 12‑Month Price Target Raised to $291.46, Implies 9% Upside
Analysts have raised the 12-month average price target for Charles River Laboratories International, Inc. (CRL) stock from $285.54 to $291.46, implying a 9% potential upside based on its August 7th closing price. The consensus rating from 19 analysts remains "Buy," with a majority recommending …
The Cheapest Harley-Davidson That Still Feels Properly American
Harley-Davidson has introduced the 2026 Deadwood, a factory bobber designed to evoke the raw, stripped-down aesthetic of postwar American motorcycles. Priced at $17,999, it's $2,000 less than the Heritage Classic it's based on, offering a powerful Milwaukee-Eight 117 engine and modern electronics beneath its …
TD Cowen Adjusts PT on Charles River Laboratories International to $300 From $235, Maintains Buy Rating
TD Cowen has increased its price target for Charles River Laboratories International (CRL) to $300 from $235, while reiterating a Buy rating on the stock. This adjustment comes amidst other analyst updates for the company, indicating positive sentiment following recent financial announcements. The article …
ALBEMARLE CORPORATION : MORGAN STANLEY CUTS TARGET PRICE TO $161.00 FROM $189.00
Morgan Stanley has adjusted its target price for Albemarle Corporation (ALB), reducing it to $161.00 from the previous $189.00. This update indicates a revised outlook from the investment bank regarding the company's valuation. The report was issued by Reuters.
Schwab: Retail investors want AI stocks on the cheap
Illustration: Brendan Lynch/Axios Retail investors took advantage of the volatility in the market last month to again be net buyers of stocks, new data from Charles Schwab shared exclusively with Axios shows. Why it matters: The trade in AI stocks shows staying power, as …
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. : TD COWEN RAISES TARGET PRICE TO $300 FROM $235
TD Cowen has increased its target price for Charles River Laboratories International, Inc. (CRL.N) to $300 from $235. This update reflects a change in the analyst's outlook for the company's stock. The article is a brief news alert from Reuters regarding this financial analyst …
Franklin Street Advisors Inc. NC Sells 102,899 Shares of Carlyle Group Inc. $CG
Franklin Street Advisors Inc. NC reduced its stake in Carlyle Group Inc. by 15.5%, selling 102,899 shares but still retaining 560,327 shares valued at approximately $23.6 million. The Carlyle Group exceeded Q2 earnings expectations with $1.07 EPS against a $0.91 consensus, and revenue of …
Pacer Advisors Inc. Has $1.16 Million Stake in Darling Ingredients Inc. $DAR
Pacer Advisors Inc. significantly reduced its stake in Darling Ingredients Inc. (NYSE:DAR) by 88.5% in the first quarter, now holding 18,784 shares valued at $1.16 million. Despite this, institutional investors collectively own 94.44% of the company, which recently reported strong quarterly results with EPS …
Schwab Charles Insider Sold Shares Worth $1,999,016, According to a Recent SEC Filing
An insider at Charles Schwab recently sold shares valued at $1,999,016, as detailed in a new SEC filing. This transaction involved the sale of company stock by an individual considered to be an insider. The filing provides transparent information about this significant financial move.
Assenagon Asset Management S.A. Raises Position in Albemarle Corporation $ALB
Assenagon Asset Management S.A. significantly increased its stake in Albemarle Corporation (NYSE:ALB) by 331.0% in the second quarter, now owning 203,996 shares worth $27.5 million. Other institutional investors like Earnest Partners LLC, Northern Trust Corp, Goldman Sachs Group Inc., Norges Bank, and Phoenix Financial …
Darling Ingredients (DAR) Could Be 21% Undervalued On Buyback And Strong Earnings
Darling Ingredients (DAR) appears to be 21% undervalued based on analyst targets and intrinsic estimates, trading at US$59 compared to a fair value of $75.42. The company recently increased its share repurchase authorization to US$1 billion and released strong quarterly results, signaling potential for …
Charles Schwab Corp (SCHW) Stock Analysis & Forecast
This article provides an analysis and forecast for Charles Schwab Corp (SCHW) stock, highlighting its current market performance and future outlook. It covers news about Schwab considering entry into prediction markets and discusses why the stock might outperform tech in a "Great Rotation." The …
Sharemaestro market context Trend signal active 52 weeks +17.1% · Next-week setup positive 59.9%Tilley Harley-Davidson Hosts Freedom Revival 70's Classic Motorcycle Show in Statesville, NC on Aug 29, 2026
1970s Shovelheads and Ironheads take center stage with the AMCA Blue Ridge Chapter, while Tilley Harley-Davidson highlights two pre-owned CVO Street Glide motorcycles currently available for sale STATESVILLE, N.C., Aug. 9, 2026 /PRNewswire/ -- Tilley Harley-Davidson will host Freedom Revival, a 1970s-themed classic motorcycle …
Sharemaestro market context Trend signal active 52 weeks +14.6%How Darling Ingredients Inc. (DAR) Affects Rotational Strategy Timing
Darling Ingredients Inc. (DAR) is showing weak near and mid-term sentiment, potentially challenging a strong long-term outlook. AI models have generated three trading strategies: a Position Trading Strategy, a Momentum Breakout Strategy, and a Risk Hedging Strategy, with a notable 40.4:1 risk-reward setup targeting …
Charles River Laboratories International (CRL) Cuts Guidance, Is It Still Undervalued?
Charles River Laboratories International (CRL) recently cut its 2026 GAAP earnings guidance and reported a quarterly net loss, despite a strong rebound in share price momentum. The article explores two contrasting valuation narratives: one suggesting the stock is 14.7% undervalued based on primate supply …